Transverse Myelitis Association
Journal Volume 2 - April 2007
Article 4
The second paper published in the Journal of Experimental Medicine in 2005, details definitive experiments performed by Dr. Vanda Lennon and colleagues at Mayo Clinic that identified aquaporin-4 as the target of NMO-IgG. Reproduced from The Journal of Experimental Medicine, 2005, 202: 473-477. Copyright 2005 The Rockefeller University Press. |
Go to Next Page
Go to Previous Page
Go to Newsletter Index
Go to Main Page
Copyright © 2011 The Transverse Myelitis Association. All rights reserved.
Document: http://www.myelitis.org/newsletters/j2/journal-2-04.htm
Last Modified: Wednesday, 07-Sep-2011 20:56:44 MST